Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Stomach Neoplasms 7Colorectal Neoplasms 6Neoplasms 4Neoplasm Metastasis 4Esophageal Neoplasms 4Pancreatic Neoplasms 3Gallbladder Neoplasms 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Ovarian Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Bile Duct Neoplasms 2Prostatic Neoplasms 1Oesophagogastric Cancer 1Head and Neck Neoplasms 1HER2 Positive Esophagogastric Cancer 1Gastrointestinal Neoplasms 1GastroEsophageal Cancer 1Esophageal Squamous Cell Carcinoma 1Dysgerminoma 1Central Nervous System Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1

Interventions

Taxes 1Paclitaxel 1Lapatinib 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dysgerminoma × Lapatinib × Gastrointestinal × Clear all
NCT00313599 2014-07-02

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

University of California, San Francisco

Phase 1 Completed
28 enrolled
BreastCNSGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Dysgerminoma, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡